We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Novavax COVID vaccine strikes nearer to full FDA approval
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Novavax COVID vaccine strikes nearer to full FDA approval
Novavax COVID vaccine strikes nearer to full FDA approval
Health

Novavax COVID vaccine strikes nearer to full FDA approval

Last updated: April 25, 2025 11:33 pm
Editorial Board Published April 25, 2025
Share
SHARE

by I. Edwards

Novavax’s COVID-19 vaccine may quickly obtain full approval from the U.S. Meals and Drug Administration (FDA), the corporate mentioned Wednesday.

The replace despatched Novavax’s refill greater than 21% in early buying and selling. It additionally helped ease fears that the choice had been delayed by the Trump Administration, The Related Press reported.

Novavax makes the one protein-based COVID-19 vaccine that is nonetheless out there in the US. Proper now, it’s only authorised underneath emergency use. That is totally different from the mRNA vaccines from Pfizer and Moderna, which have full FDA approval for sure age teams.

In a brand new assertion, Novavax mentioned the FDA has requested the corporate to gather extra scientific information from individuals who obtain its shot.

The corporate added that it’s “engaging with the FDA expeditiously” in hopes to get full approval “as soon as possible.”

Below emergency use, vaccines could be eliminated even after a well being emergency is taken into account to be over. Full approval from the FDA means a product can keep in the marketplace even after a well being emergency ends. (The World Well being Group declared an finish to the COVID emergency in Could 2023.)

The vaccine was on observe for FDA approval by April 1. However appearing FDA Commissioner Dr. Sara Brenner instructed the company to pause the choice, AP mentioned.

This sparked issues that U.S. Well being Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, could have influenced the delay. FDA vaccine chief Dr. Peter Marks stepped down final month after clashing with Kennedy over vaccine security.

The COVID vaccines used within the U.S. prepare the physique to acknowledge the tell-tale spike protein on the SARS-CoV2 virus.

In contrast to the Pfizer and Moderna vaccines, which depend on a genetic code to set off an immune response, Novavax’s vaccine combines lab-grown copies of the spike protein with an agent that helps enhance the immune system.

Every year, vaccine makers replace their COVID-19 photographs to raised goal new variants, very similar to how flu photographs are modified yearly.

© 2025 HealthDay. All rights reserved.

Quotation:
Novavax COVID vaccine strikes nearer to full FDA approval (2025, April 25)
retrieved 25 April 2025
from https://medicalxpress.com/information/2025-04-novavax-covid-vaccine-closer-full.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

Music remedy could ease misery for dementia sufferers in hospital wards

Eye scan can reveal danger of getting a coronary heart assault or stroke

Eight infants born after mitochondrial donation therapy to scale back transmission of mitochondrial DNA illness

WHO, UNICEF say greater than 14 million infants worldwide stay unvaccinated

Common train might assist forestall fatty liver illness by means of bile acid metabolism

TAGGED:approvalcloserCOVIDFDAfullmovesNovavaxvaccine
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Day by day Information and different retailers ask choose to reject OpenAI effort to maintain deleting knowledge
New York

Day by day Information and different retailers ask choose to reject OpenAI effort to maintain deleting knowledge

Editorial Board June 18, 2025
How Roman Abramovich, a Russian Oligarch, Found Himself Under Sanctions
Recreation.gov, the National Park Booking App, Leaves Users Feeling Lost in the Woods
A Divided World United to Launch the James Webb Space Telescope
House Panel Subpoenas Roger Stone and Alex Jones in Capitol Riot Inquiry

You Might Also Like

From tea towels to TV remotes: Eight on a regular basis bacterial hotspots, and the best way to clear them
Health

From tea towels to TV remotes: Eight on a regular basis bacterial hotspots, and the best way to clear them

July 16, 2025
Sufferers who really feel heard usually tend to stick to medical therapy
Health

Sufferers who really feel heard usually tend to stick to medical therapy

July 16, 2025
How the mind will increase blood circulate on demand
Health

How the mind will increase blood circulate on demand

July 16, 2025
Will RFK Jr.’s push for psychedelic remedy assist or hamper the rising area?
Health

Will RFK Jr.’s push for psychedelic remedy assist or hamper the rising area?

July 16, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?